← Back to Clinical Trials
Recruiting NCT07606300

NCT07606300 Effect of Fixation Training With Colored Light Targets on Traumatic Brain Injury-Associated Photophobia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07606300
Status Recruiting
Phase
Sponsor Ohio State University
Condition Traumatic Brain Injury (TBI) Patients
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2005-01
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Fixation training using different colored fixation targets

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2005-01 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Many people develop intolerance to light after a head injury, leading to ambient light levels causing discomfort. We do not fully understand why this occurs and how it should be treated. A growing number of clinicians have reported improvement in TBI related symptoms reported by patients that undergo daily fixation training with a dim light target. While fixation training using various colored light targets is reported, blue light targets specifically appear to be used in this patient population more often than other light target colors. However, the effectiveness of this approach has yet to be assessed in a well-controlled clinical study. In this work, we will recruit individuals who had a recent brain injury and developed increased light sensitivity. Participants will be divided into two groups: one that first uses daily 20 minute sessions for 12 weeks with the at-home fixation device set to display a blue light target; and another that will undergo similar sessions for 12 weeks using a red light target. Every 6 weeks, masked examiners will measure how well participants can read letters on an eye chart, record pupil responses to light, measure the side vision, measure eye alignment and focusing ability when viewing a near target, and collect information about participants' symptoms. In a cross-over study design, the participants will then switch to sessions involving the other colored fixation light target for another 12 weeks, with data being again collected every 6 weeks. Potential differences in pupil responses to light between the treatment groups will be assessed as an objective outcome measure and compared to subjective symptom survey information. Thus, this work will test the hypothesis that daily fixation training using a blue light target can alleviate light intolerance in participants after head injury more than fixation training with a red light target, and this improvement is associated with altered pupil responses to light. As a significant minority of eye care clinicians currently utilize this approach in this population of patients, this study has the potential to influence clinical practice patterns whether the fixation training is shown to be effective or not.

Eligibility Criteria

Inclusion Criteria: * 18 to 80 years old and subjects able to consent for themselves * Completion of first session in entirety (participants who cannot complete the entire first visit will be considered as a screen fail) * Best-corrected visual acuity of at least 20/32 in both the right and left eyes, and 20/25 using both eyes * Prior head injury with current photophobia - A mild or moderate TBI occurring at least 3 months prior to visit, verified by a score of 2, 3 or 4 on OSU-TBI survey, and participant reports having experienced greater light sensitivity since their head injury Exclusion Criteria: * Pregnancy or suspected pregnancy - based on self-report * Previous history of neurodegenerative disease (e.g. Alzheimer's, Parkinson's, multiple sclerosis, myasthenia gravis, seizures) * History of pathology of the retina and optic nerve (includes retinal tears, diabetic retinopathy, glaucoma, macular degeneration, optic nerve atrophy) * Currently on cholinergic medications, which affect pupil responses * Prior participation in fixation training sessions within the past 2 years * Experiencing a migraine during visit * Prior history of severe TBI (score of 5 or 6 on OSU-TBI survey)

Contact & Investigator

Central Contact

Andrew Hartwick, OD, PhD

✉ HARTWICK.4@osu.edu

📞 16146888308

Frequently Asked Questions

Who can join the NCT07606300 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Traumatic Brain Injury (TBI) Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07606300 currently recruiting?

Yes, NCT07606300 is actively recruiting participants. Contact the research team at HARTWICK.4@osu.edu for enrollment information.

Where is the NCT07606300 trial being conducted?

This trial is being conducted at Columbus, United States.

Who is sponsoring the NCT07606300 clinical trial?

NCT07606300 is sponsored by Ohio State University. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology